The stock of Health Catalyst Inc (HCAT) has seen a 7.20% increase in the past week, with a -19.28% drop in the past month, and a -36.33% decrease in the past quarter. The volatility ratio for the week is 5.55%, and the volatility levels for the past 30 days are at 4.59% for HCAT. The simple moving average for the past 20 days is -5.71% for HCAT’s stock, with a -35.93% simple moving average for the past 200 days.
Is It Worth Investing in Health Catalyst Inc (NASDAQ: HCAT) Right Now?
HCAT has 36-month beta value of 1.34. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for HCAT is 55.71M, and currently, short sellers hold a 2.72% ratio of that float. The average trading volume of HCAT on April 25, 2024 was 618.44K shares.
HCAT) stock’s latest price update
Health Catalyst Inc (NASDAQ: HCAT) has seen a rise in its stock price by 7.68 in relation to its previous close of 5.60. However, the company has experienced a 7.20% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-04-08 that Health Catalyst (HCAT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Analysts’ Opinion of HCAT
Evercore ISI, on the other hand, stated in their research note that they expect to see HCAT reach a price target of $11. The rating they have provided for HCAT stocks is “Outperform” according to the report published on January 03rd, 2024.
Barclays gave a rating of “Overweight” to HCAT, setting the target price at $14 in the report published on January 03rd of the current year.
HCAT Trading at -21.40% from the 50-Day Moving Average
After a stumble in the market that brought HCAT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -58.04% of loss for the given period.
Volatility was left at 4.59%, however, over the last 30 days, the volatility rate increased by 5.55%, as shares sank -19.49% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -41.23% lower at present.
During the last 5 trading sessions, HCAT rose by +7.20%, which changed the moving average for the period of 200-days by -51.02% in comparison to the 20-day moving average, which settled at $6.32. In addition, Health Catalyst Inc saw -34.88% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HCAT starting from Llewelyn Linda, who sale 2,005 shares at the price of $6.11 back on Apr 15 ’24. After this action, Llewelyn Linda now owns 126,226 shares of Health Catalyst Inc, valued at $12,251 using the latest closing price.
Llewelyn Linda, the Chief People Officer of Health Catalyst Inc, sale 2,005 shares at $7.80 during a trade that took place back on Mar 15 ’24, which means that Llewelyn Linda is holding 128,231 shares at $15,648 based on the most recent closing price.
Stock Fundamentals for HCAT
Current profitability levels for the company are sitting at:
- -0.39 for the present operating margin
- 0.42 for the gross margin
The net margin for Health Catalyst Inc stands at -0.4. The total capital return value is set at -0.19. Equity return is now at value -29.84, with -16.25 for asset returns.
Based on Health Catalyst Inc (HCAT), the company’s capital structure generated 0.39 points at debt to capital in total, while cash flow to debt ratio is standing at -0.14. The debt to equity ratio resting at 0.63. The interest coverage ratio of the stock is -13.9.
Currently, EBITDA for the company is -40.55 million with net debt to EBITDA at -1.97. When we switch over and look at the enterprise to sales, we see a ratio of 1.68. The receivables turnover for the company is 4.84for trailing twelve months and the total asset turnover is 0.42. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.39.
Conclusion
To put it simply, Health Catalyst Inc (HCAT) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
